Thomas F Eleveld

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 4

Top Topics

Lymph Node Metastasis

Top Venues

Cancer research

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Nucleic acids research

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas F Eleveld, Chaimaa Bakali, Paul P Eijk, Phylicia Stathi, Lianne E Vriend, Pino J Poddighe, Bauke Ylstra
Engineering large-scale chromosomal deletions by CRISPR-Cas9. Nucleic acids research 49 (21) (2022)
Dennis M Timmerman, Thomas F Eleveld, Sruthi Sriram, Lambert C J Dorssers, Ad J M Gillis, Silvia Schmidtova, Katarina Kalavska, Harmen J G van de Werken, Christoph Oing, Friedemann Honecker, Michal Mego, Leendert H J Looijenga
Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (26) (2022)
Caroline C C Hulsker, Mariëtte E G Kranendonk, Thomas F Eleveld, Ad J M Gillis, Cornelis P van de Ven, Natasha K A Van Eijkelenburg, Niels P van der Kaaij, Alida F W van der Steeg, Leendert H J Looijenga
Recurrence of a Mediastinal Germ-Cell Tumor as a Somatic-Type Malignancy: A Complex Case Report. International journal of molecular sciences 22 (17) (2021)
Thomas F Eleveld, Linda Schild, Jan Koster, Danny A Zwijnenburg, Lindy K Alles, Marli E Ebus, Richard Volckmann, Godelieve A Tijtgat, Peter van Sluis, Rogier Versteeg, Jan J Molenaar
RAS-MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in Neuroblastoma. Cancer research 78 (21) (2018)